共 50 条
- [21] MBRC-101: a novel antibody-drug conjugate (ADC) targeting the membraneassociated tyrosine kinase receptor EphA5 in breast cancerCANCER RESEARCH, 2024, 84 (09)Staquicini, FernandaTang, Fennyde Oliveira, VanessaStaquicini, DanielaWu, YongjianBarnhart, KirstinParsons, J. KelloggArap, WadihChen, IsanPasqualini, Renata
- [22] Characterization of SGN-CD123A, APotent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid LeukemiaMOLECULAR CANCER THERAPEUTICS, 2018, 17 (02) : 554 - 564Li, FuSutherland, May KungYu, ChangpuWalter, Roland B.Westendorf, LoriValliere-Douglass, JohnPan, LucyCronkite, AshleySussman, DjangoKlussman, KerryUlrich, MichelleAnderson, Martha E.Stone, Ivan J.Zeng, WeipingJonas, MechthildLewis, Timothy S.Goswami, MaitrayeeWang, Sa A.Senter, Peter D.Law, Che-LeungFeldman, Eric J.Benjamin, Dennis R.
- [23] Potent in Vitro and In Vivo Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid LeukemiaBLOOD, 2023, 142van der Lee, Mirandavan Achtenberg, TanjaBrouwers-Vos, Annetvan der Vleuten, MoniqueKappers, WendyVerheijden, GijsHuls, Geert A.van Wigcheren, GlennUbink, RuudSesink, AloysMacInnes, AlysonSchuringa, Jan JacobDokter, Wim
- [24] Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I studyLEUKEMIA RESEARCH, 2020, 95Goldberg, Aaron D.Atallah, EhabRizzieri, DavidWalter, Roland B.Chung, Ki-YoungSpira, AlexanderStock, WendyTallman, Martin S.Cruz, Hans G.Boni, JosephHavenith, Karin E. G.Chao, GraceFeingold, Jay M.Wuerthner, JensSolh, Melhem
- [25] BYON4413, an in vivo active CD123-targeting antibody-drug conjugate, combines effectively with azacitidine and venetoclax in acute myeloid leukemia cell linesCANCER RESEARCH, 2024, 84 (06)van der Lee, Miranda M. C.van Achterberg, TanjaHersmus, KayleeBrouwers-Vos, Annetvan der Vleuten, MoniquePruis, MaurienKappers, WendyVerheijden, GijsHuls, Gerwinvan Wigcheren, GlennUbink, RuudSesink, AloysMacInnes, AlysonSchuringa, Jan JacobDokter, Wim
- [26] Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemiaCANCER LETTERS, 2008, 268 (02) : 314 - 324Hong, Chih-ChenLay, Jong-DingHuang, Jhy-ShrianCheng, Ann-LiiTang, Jih-LuhLin, Ming-TsehLai, Gi-MingChuang, Shuang-En
- [27] Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy (vol 7, 75, 2019)JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7Yao, Hang-PingFeng, LiangSuthe, Sreedhar ReddyChen, Ling-HuiWeng, Tian-HaoHu, Chen-YuJun, Eun SungWu, Zhi-GangWang, Wei-LinKim, Song CheolTong, Xiang-MinWang, Ming-Hai
- [28] Maturing Clinical Profile of IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Acute Myeloid LeukemiaBLOOD, 2018, 132Cortes, Jorge E.DeAngelo, Daniel J.Erba, Harry P.Traer, EliePapadantonakis, NikolaosArana-Yi, CeciliaBlum, WilliamSloss, Callum M.Culm-Merdek, KerryZweidler-McKay, Patrick A.Wang, Eunice S.
- [29] Pivekimab Sunirine (PVEK, IMGN632), a CD123-Targeting Antibody-Drug Conjugate, in Combination with Azacitidine and Venetoclax in Patients with Newly Diagnosed Acute Myeloid LeukemiaBLOOD, 2023, 142Daver, NavalMontesinos, PauAltman, Jessica K.Wang, Eunice S.Martinelli, GiovanniRoboz, Gail J.Begna, KebedeVyas, PareshLunghi, MoniaPlatzbecker, UweBurke, Patrick W.Walter, Roland B.Advani, Anjali S.Garciaz, SylvainGastaud, LaurisSallman, David A.Pemmaraju, NaveenTorres, LauraAbaza, YasminChan, OnyeeKantarjian, Hagop M.Oshrine, BenjaminDu, YiningMalcolm, KaraSweet, Kendra
- [30] Synergistic antileukemic activity of the antibody-drug conjugate (IMGN779) combined with PARP inhibition in preclinical human acute myeloid leukemia modelsCANCER RESEARCH, 2018, 78 (13)Fritz, ClairePortwood, Scott M.Adams, JulieWang, Eunice S.